                         SEQUENCE LISTING

<110>  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
       Robichaux, Jacqulyne
       Nilsson, Monique
       Heymach, John  V
 
<120>  COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING 
       EGFR OR HER2 EXON 20 MUTATIONS

<130>  UTFC.P1306WO

<150>  62423732
<151>  2016-11-11

<150>  62427692
<151>  2016-11-29

<150>  62572716
<151>  2017-10-16

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EGFR mutation

<400>  1

Phe Gln Glu Ala 
1               


<210>  2
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EGFR mutation

<400>  2
tccaggaagc ct                                                           12


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HER2 mutation

<400>  3

Tyr Val Met Ala 
1               


<210>  4
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HER2 mutation

<400>  4
tatgtcatgg ct                                                           12


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  5
cttacaccca gtggagaagc                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  6
accaagcgac ggtcctccaa                                                   20


<210>  7
<211>  45
<212>  DNA
<213>  Homo sapiens

<400>  7
gaagcctacg tgatggccag cgtggacaac ccccacgtgt gccgc                       45


<210>  8
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EGFR exon 20 A763insFQEA

<400>  8
gaagcctcca ggaagcctta cgtgatggcc agcagcgtgg acgtggacaa cccccacgtg       60

tgccgc                                                                  66


<210>  9
<211>  45
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EGFR exon 20 S768dupSVD

<400>  9
gaagcctacg tgatggccag cgtggacaac ccccacgtgt gccgc                       45


<210>  10
<211>  54
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EGFR exon 20 V769insASV

<400>  10
gaagcctacg tgatggccag cgtgccagcg tgggacaacc cccacgtgtg ccgc             54


<210>  11
<211>  54
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EGFR exon 20 D770insSVD

<400>  11
gaagcctacg tgatggccag cgtggacgcg tggacaaacc cccacgtgtg ccgc             54


<210>  12
<211>  54
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EGFR exon 20 H773insNPH

<400>  12
gaagcctacg tgatggccag cgtggacaac ccccacaacc cccacgtgtg ccgc             54


<210>  13
<211>  48
<212>  DNA
<213>  Homo sapiens

<400>  13
gaagcatacg tgatggctgg tgtgggctcc ccatatgtct cccgcctt                    48


<210>  14
<211>  48
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HER2 exon 20 G776V

<400>  14
gaagcatacg tgatggctgt tgtgggctcc ccatatgtct cccgcctt                    48


<210>  15
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HER2 exon 20 G776V V777insV

<400>  15
gaagcatacg tgatggcttg tgtgttgggc tccccatatg tctcccgcct t                51


<210>  16
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HER2 exon 20 G776del insVV

<400>  16
gaagcatacg tgatggctgt tgttgtgggc tccccatatg tctcccgcct t                51


<210>  17
<211>  52
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HER2 exon 20 G776del ins V

<400>  17
cgaagcatac gtgatggctg gtgtgtctgg ctccccatat gtctcccgcc tt               52


<210>  18
<211>  57
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HER2 exon P780insGSP

<400>  18
gaagcatacg tgatggctgg tgtgggctcc ccatggctcc cctatgtctc ccgcctt          57


